iBio Stock Price

0.0015 (0.54%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,721,850
Bid Price
Ask Price
News -
Day High 0.285


52 Week Range


Day Low 0.2701
Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0015 0.54% 0.281 19:57:09
Open Price Low Price High Price Close Price Prev Close
0.2758 0.2701 0.285 0.28 0.2795
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,127 1,721,850 $ 0.2802615 $ 482,568 - 0.22 - 1.335
Last Trade Time Type Quantity Stock Price Currency
20:00:00 1,645 $ 0.28 USD


Draw Mode:

iBio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 61.30M 218.17M 217.86M $ 2.37M $ - -0.13 -1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 3.60%

more financials information »

iBio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.26680.29550.2450.26755661,745,7550.01425.32%
1 Month0.24880.29550.220.24976451,691,5230.032212.94%
3 Months0.240.3390.220.27358292,822,3360.04117.08%
6 Months0.37930.55460.220.3149332,554,986-0.0983-25.92%
1 Year1.241.3350.220.60368072,831,733-0.959-77.34%
3 Years0.697.850.051.9110,468,414-0.409-59.28%
5 Years2.807.850.051.916,522,194-2.52-89.96%

iBio Description

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now